CSI Market
Sign In | Register

Insys Therapeutics (INSY) Annual Balance Sheets

Annual · GAAP · USD millions
Access INSY quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Insys Therapeutics's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/INSY/balance-sheets
https://api.csimarket.com/api/v1/companies/INSY/fundamentals
https://api.csimarket.com/api/v1/companies/INSY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2018)
(Dec 31 2017) (Dec 31 2016) (Dec 31 2015) (Dec 31 2014)
Assets
Cash & cash equivalent31.55
Available-for-sale Securities, Debt Securities, Current MA64.13
Cash & Short-term Investments95.00
Accounts receivable12.61
Inventories8.61
Deferred Tax Assets, Net, Current AS0.00
Prepaid Expense And Other Assets Current9.40
Total Current Assets126.29
Equipment/Property/Plant Net52.09
Long-term investments8.45
Deferred Tax Assets, Net, Noncurrent AS0.00
Other Assets, Noncurrent5.70
Total Assets192.53
Liabilities
Accounts Payable and Accrued Liabilities, Current LI50.86
Employee-related Liabilities, Current AC6.44
Estimated Litigation Liability, Current41.40
Other Liabilities, Current8.16
Liability for Uncertain Tax Positions, Current LI0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities106.86
Total Long-term Debt0.00
Estimated Litigation Liability, Noncurrent LI125.00
Deferred credits, Noncurrent0.00
Liability for Uncertain Tax Positions, Noncurrent LI3.77
Total Liabilities235.63
Stockholders' Equity
Related Party Transaction Due From To Related Party-
Common Stock Value0.74
Treasury Stock Value0.00
Additional Paid In Capital Common Stock292.51
Retained Earnings / Accumulated Deficit-336.08
Accumulated Other Comprehensive Income0.00
Other Equity-0.27
Common Stockholder's Equity-43.10
Total Stockholder's Equity-43.10
Liabilities & Stockholder's Equity192.53
4 historic quarters locked

Sign in to unlock the full Insys Therapeutics balance sheet history.

Sign In Create Free Account

About INSY Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI